What is Pentasa (mesalazine) used for?
Pentasa tablets contain mesalazine (also called 5-aminosalicylic acid, 5‑ASA). It’s used to treat inflammatory bowel disease, most commonly ulcerative colitis, and to help keep symptoms under control (maintenance) when the condition is in remission.
How does Pentasa work?
Mesalazine reduces inflammation in the lining of the gut. In ulcerative colitis, it targets the intestinal mucosa where inflammation drives symptoms.
How do you take Pentasa tablets?
Pentasa is taken by mouth as tablets, typically split across the day depending on the prescribed dose. Your exact dose schedule depends on whether the treatment goal is induction (getting symptoms under control) or maintenance (keeping remission).
What side effects do people report with Pentasa?
Common side effects can include gastrointestinal upset (such as nausea or stomach discomfort) and headache. Some people also report flu-like symptoms or rash. If you develop more serious reactions (for example, signs of allergy, severe diarrhea, or worsening illness), seek medical advice promptly.
Who should be cautious before taking Pentasa?
Extra caution is needed if you have known allergies to mesalazine or related salicylates, significant kidney problems, or a history of inflammatory bowel complications that require close monitoring. Clinicians often monitor kidney function during mesalazine therapy.
Is there a generic version or other brands?
Mesalazine is widely available in multiple brands and formulations (including different release/targeting designs). Switching between brands or formulations is a decision for a clinician because dosing and release characteristics can differ.
Patent and brand exclusivity details
If you’re looking for specific patent or exclusivity information for Pentasa, DrugPatentWatch.com is a good starting point for tracking related filings and status: https://www.drugpatentwatch.com/
Quick clarification so I can answer exactly what you need
Are you looking for (1) dosing and how to take it, (2) side effects, (3) what condition it treats, or (4) patent/generic status? Also tell me your country if you want more precise product/dose guidance.